Pinsent Masons advises Intelligent Energy on IPO

14 Jul 2014 | 01:20 pm |

International law firm Pinsent Masons has advised Intelligent Energy on its initial public offering (IPO) raising a total of £55 million.

The deal, thought to be London's biggest pure technology flotation in five years, values the green power company at $1.1bn (£639 million). Intelligent Energy intends to use the funds raised to pursue international expansion plans.

Corporate partners Rob Hutchings, Louise Wolfson and senior associate James Broadhurst led a Pinsent Masons team advising on the transaction.

Commenting on the deal, Rob Hutchings, said:
"The flotation represents a significant milestone for Intelligent Energy. It provides the funding needed to embark on ambitious growth plans as the company enters the next stage of its development.

"We are delighted to have assisted our client on a deal which is critical for their business and also demonstrates an appetite for innovative clean tech investments in the UK market."

Intelligent Energy is a longstanding client for Pinsent Masons. In 2013, the firm advised the company on its £30 million convertible loan note issuance and earlier this year advised on its issue of warrants.

Chief financial officer at Intelligent Energy, John Maguire, said: "We very much enjoyed working with the Pinsent Masons team, who in turn worked closely with ours to help us reach this important milestone in Intelligent Energy's development."

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

Pinsent Masons advises ALK Capital on its acquisition of Burnley FC

Multinational law firm Pinsent Masons has advised ALK Capital on the acquisition of Burnley Football Club.

Pinsent Masons advises Unbound on financing in fitness start-up VAHA

Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts